New cystic fibrosis drug tested for safety and how body processes it

NCT ID NCT05090904

Completed Disease control Sponsor: Insmed Incorporated Source: ClinicalTrials.gov ↗

First seen Mar 18, 2026 · Last updated Apr 20, 2026 · Updated 3 times

Summary

This study tested a new oral tablet called brensocatib in adults with cystic fibrosis. Researchers wanted to understand how the drug moves through the body and check its safety over a 4-week period. The trial involved 29 participants who took either the drug or a placebo, and it focused on measuring drug levels in the blood and tracking any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

USA001

Gainesville, Florida, 32610, United States
USA002

St Louis, Missouri, 63101, United States
USA003

Tyler, Texas, 75708, United States
USA004

Dallas, Texas, 75390, United States
USA006

Cleveland, Ohio, 44195, United States
USA008

Cleveland, Ohio, 44106, United States
USA009

Charleston, South Carolina, 29425, United States
USA011

Boston, Massachusetts, 02115, United States
USA016

Augusta, Georgia, 30912, United States
USA017

Nashville, Tennessee, 37232, United States
USA018

Portland, Oregon, 97239, United States
USA022

New York, New York, 10032, United States
USA023

Ann Arbor, Michigan, 48109, United States
USA025

Glenview, Illinois, 60025, United States

Conditions

Explore the condition pages connected to this study.

CYSTIC FIBROSIS